Toronto, ON (PRWEB) March 23, 2011
Infrastructures for Information (i4i) Inc., a world leader in the design and development of collaborative content solutions and technologies for life sciences, is pleased to announce that they will be exhibiting at the DIA's 23rd Annual EuroMeeting, March 28 - 30 in Geneva, Switzerland.
Conference attendees are invited to visit booth 1081 where the i4i team will showcase A4L Enterprise 4.1 for Global Labelling, a robust, life-cycle tool for authoring, managing, publishing and submitting drug product documents. With its suite of web services, A4L addresses the complexity of regulatory processes and requirements in both Europe (PIM, CP, MRP, DCP) and the US (SPL). Based on an integrated content model, information from corporate documents (CCDS, Corporate Patient Information, etc.) can be incorporated, tracked and reused.
- A4L is built on management and XML services that support content development and collaboration across many business areas within a pharmaceutical drug product provider. A4L is suitable for regulatory requirements and business processes that range from a single, authoritative view of label content to the exchange of content between multiple authorities. This flexible platform can be delivered to a diverse group of users across locations and can be deployed as a hosted or installed solution.
- The User Interface provides work areas and dashboards in one intuitive view. Dashboards to manage Variants, Translations, Collaboration and Relations can be configured according to user authority and needs, enabling business-specific processes and key interaction for specific authoring, publishing and validation functions.
- The Collaborations Dashboard graphically highlights the parallel review and authoring process, managing the flow of work on documents from users across versions and locations. Parallel authoring and review can be highlighted and managed, enabling content reuse across documents.
- Folder Structures can be set up to highlight specific departmental resources currently being interacted with. XML Technology allows for external tools and applications to be easily integrated. Messaging, translations, text verification and desktop publishing tools can be added allowing users to create, review and manage these processes within a very collaborative environment.
The A4L Enterprise platform for Global Labeling encourages growth and interaction, letting drug manufacturers expand the authoring, managing and auditing of labels across departments and jurisdictions. The web-services model enables the platform to be rolled out to a diverse group of users, who can seamlessly author, manage, audit and submit content across the globe.
A4L's web-based platform allows collaboration between local and geographically-distributed content authors and reviewers. Content can be re-used across documents, further driving efficiencies and improving document quality and compliance - by ensuring all parties are using correct and pre-approved content.
Based in Toronto, Canada, i4i (http://www.i4i.com) is a world leader in the design and development of collaborative, XML-based, content solutions and technologies. i4i has a proven record of accomplishment and innovation, having authored international standards and patented its technology. Through the use of i4i's comprehensive suite of products, life science companies can author, verify, submit and manage product labeling requirements across the globe. i4i has successfully developed and deployed collaborative content solutions to life science customers around the world.
About the Drug Information Association (DIA)
DIA is a neutral, global, professional, member-driven association of nearly 18,000 professionals involved in the discovery, development, and life cycle management of pharmaceuticals, biotechnology, medical devices, and related healthcare products. Through our international educational offerings and myriad networking opportunities, DIA provides a global forum for knowledge exchange that fosters the innovation of products, technologies, and services to improve health and well-being worldwide. Headquarters are in Horsham, PA, USA, with offices in Switzerland, India and China.